CompletedPhase 3NCT02770807
Intra-Erythrocyte Dexamethasone Sodium Phosphate in Ataxia Telangiectasia Patients
Studying Ataxia-telangiectasia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Quince Therapeutics S.p.A.
- Principal Investigator
- Guenter R. Janhofer, MD, PhDEryDel S.p.A
- Intervention
- EryDex Low dose DSP(drug)
- Enrollment
- 176 enrolled
- Eligibility
- 6 years · All sexes
- Timeline
- 2017 – 2021
Study locations (22)
- UCLA-Ataxia Center and HD Center of Exellence, Los Angeles, California, United States
- The Ataxia-Telangiectasia Clinical Center, The Johns Hopkins Hospital, Baltimore, Maryland, United States
- Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
- UT Health, Houston, Texas, United States
- Royal Children's Hospital, Melbourne, Victoria, Australia
- Laboratoriumgeneeskunde, Leuven, Belgium
- Klinik für Kinder- und Jugendmedizin Pädiatrische Allergologie, Pneumologie und Mukoviszidose, Universitätsklinikum Frankfurt, Frankfurt am Main, Hesse, Germany
- National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India
- Amrita Institute of Medical Sciences and Research Centre, Kochi, Kerala, India
- Jaslok Hospital and Research Centre, Mumbai, Maharashtra, India
- PD Hinduja National Hospital and Medical Research, Mahīm, Mumbai, India
- Vijaya Health Centre, Department of Neurology, Chennai, Tamil Nadu, India
- Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India
- All India Institute of Medical Sciences, New Delhi, India
- Sheba Medical Center, Tel Litwinsky, Israel
- +7 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02770807 on ClinicalTrials.govOther trials for Ataxia-telangiectasia
Additional recruiting or active studies for the same condition.